 |
 |
|
|
|
| Mitomycin C |
 |
| C15H18N4O5 |
 |
| 50-07-7 |
 |
| Clinical suitable for gastrointestinal cancer, stomach cancer, colon cancer, liver cancer and pancreatic cancer, the better effect. Lung cancer, breast cancer, cervical cancer, and choriocarcinoma cancer. Can also be used for malignant lymphoma, malignant ascites and pleural effusion |
 |
Mitomycin C
CAS No.: 50-07-7
MF: C15H18N4O5
Molecular Weight: 334.33
EINECS No.: 200-008-6
Use: Clinical suitable for gastrointestinal cancer, stomach cancer, colon cancer, liver cancer and pancreatic cancer, the better effect. Lung cancer, breast cancer, cervical cancer, and choriocarcinoma cancer. Can also be used for malignant lymphoma, malignant ascites and pleural effusion |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
